| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 10/01/2014 | EP2782601A2 Il-1 binding proteins |
| 10/01/2014 | EP2782600A1 Combination therapy using anti - cd20 antibody and human il-15 |
| 10/01/2014 | EP2782599A2 Administration of alpha4beta7 hetero-dimer-specific antibody |
| 10/01/2014 | EP2782598A2 Recombinant proteins and their therapeutic uses |
| 10/01/2014 | EP2782597A1 Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
| 10/01/2014 | EP2782596A1 Virus vectors for highly efficient transgene delivery |
| 10/01/2014 | EP2782595A1 Malaria vaccine |
| 10/01/2014 | EP2782594A1 Method for preparation of aluminum hydroxyphosphate adjuvant |
| 09/30/2014 | USRE45170 Streptococcus suis vaccines and diagnostic tests |
| 09/30/2014 | US8849441 Systems, devices, and methods for making or administering frozen particles |
| 09/30/2014 | US8847005 Genetically modified major histocompatibility complex mice |
| 09/30/2014 | US8846893 Non-ionically bound constructs, and compositions and kits comprising domains |
| 09/30/2014 | US8846891 Infectious genotype 1a, 1b, 2a, 2b, 3a, 5a, 6a and 7a hepatitis C virus lacking the hypervariable region 1 (HVR1) |
| 09/30/2014 | US8846874 IgG Fc fragment for a drug carrier and method for the preparation thereof |
| 09/30/2014 | US8846873 Antibodies directed to GPNMB and uses thereof |
| 09/30/2014 | US8846871 Anti-Notch1 NRR antibodies |
| 09/30/2014 | US8846868 Anti-AREG/HB-EGF antibodies and treatment |
| 09/30/2014 | US8846621 Compositions and methods for treating diseases associated with angiogenesis and inflammation |
| 09/30/2014 | US8846617 Inflammation inhibiting compounds |
| 09/30/2014 | US8846609 Leukotoxin E/D as a new anti-inflammatory agent and microbicide |
| 09/30/2014 | US8846397 Immunoregulation by anti-ILT5 antibodies and ILT5-binding antibody fragments |
| 09/30/2014 | US8846388 Infectious clones of torque teno virus |
| 09/30/2014 | US8846342 Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells |
| 09/30/2014 | US8846308 Method for identifying immune response modulators |
| 09/30/2014 | US8846098 Artificial cell constructs for cellular manipulation |
| 09/30/2014 | US8846080 Vaccine |
| 09/30/2014 | US8846078 Brucellosis DNA vaccine |
| 09/30/2014 | US8846059 Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer |
| 09/30/2014 | US8846058 Shiga toxoid chimeric proteins |
| 09/30/2014 | US8846057 Recombinant live attenuated foot-and-mouth disease (FMD) vaccine containing mutations in the L protein coding region |
| 09/30/2014 | US8846056 Anti-RSV immunogens and methods of immunization |
| 09/30/2014 | US8846055 Virulence determinant within the E2 structural glycoprotein of classical swine fever virus |
| 09/30/2014 | US8846054 Method of treating pregnant cows and/or heifers |
| 09/30/2014 | US8846052 Bacterial toxin vaccine |
| 09/30/2014 | US8846051 Modulation of replicative fitness by deoptimization of synonymous codons |
| 09/30/2014 | US8846050 N-domain of carcinoembryonic antigen and compositions, methods and uses thereof |
| 09/30/2014 | US8846049 Process for manufacturing vaccines |
| 09/30/2014 | US8846048 Compositions and methods for diagnosis, prognosis and management of malaria |
| 09/30/2014 | US8846047 Monoclonal antibodies against HMGB1 |
| 09/30/2014 | US8846046 Low dose methods for treating disorders in which TNFα activity is detrimental |
| 09/30/2014 | US8846045 Anti-C5a receptor antibodies |
| 09/30/2014 | US8846044 Stabilizing alkylglycoside compositions and methods thereof |
| 09/30/2014 | US8846043 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
| 09/30/2014 | US8846042 Multi-specific FAB fusion proteins and methods of use |
| 09/30/2014 | US8846041 Anti-LRP6 antibodies |
| 09/30/2014 | US8846040 Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 09/30/2014 | US8846039 Method for ameliorating pruritus |
| 09/30/2014 | US8846038 Method for treating synovial sarcoma |
| 09/30/2014 | US8846037 Antibodies to IL-6 and their uses |
| 09/30/2014 | US8846032 MDCK cell lines supporting viral growth to high titers and bioreactor process using the same |
| 09/30/2014 | US8846026 Composition comprising immunogenic microparticles |
| 09/30/2014 | US8846002 Anti-CD74 immunoconjugates and methods of use |
| 09/30/2014 | CA2606102C Modulation of antibody effector function by hinge domain engineering |
| 09/30/2014 | CA2590935C Fc.gamma.riib-specific antibodies and methods of use thereof |
| 09/30/2014 | CA2570156C Needle-free administration of felv vaccines |
| 09/30/2014 | CA2535489C Antibodies against factor viii with modified glycosylation in the variable region |
| 09/30/2014 | CA2506737C Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia (b-cll) |
| 09/30/2014 | CA2252439C Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
| 09/25/2014 | WO2014153514A2 Contraceptive vaccines for mammals |
| 09/25/2014 | WO2014153435A1 Methods for treating osteogenesis imperfecta |
| 09/25/2014 | WO2014153241A1 Treatment of staphylococcal disorders |
| 09/25/2014 | WO2014153195A1 Monoclonal antibodies against antithrombin beta complexed with heparin |
| 09/25/2014 | WO2014153168A2 Porcine astrovirus sequences and uses thereof |
| 09/25/2014 | WO2014153164A1 Targeting agent antibody conjugates and uses thereof |
| 09/25/2014 | WO2014153153A1 Compositions and methods for treating inflammatory diseases |
| 09/25/2014 | WO2014153150A1 Methods of predicting anti ctla-4 response and recurrence of cancer |
| 09/25/2014 | WO2014153087A1 Nanoparticle-based compositions |
| 09/25/2014 | WO2014153056A2 Cancer treatment using antibodies that bing cell surface grp78 |
| 09/25/2014 | WO2014153018A1 Use of egfr biomarkers for the treatment of gastric cancer with anti-egfr agents |
| 09/25/2014 | WO2014153002A1 Bispecific antibodies and uses thereof |
| 09/25/2014 | WO2014152841A1 Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy |
| 09/25/2014 | WO2014152534A1 Recombinant rsv with silent mutations, vaccines, and methods related thereto |
| 09/25/2014 | WO2014152358A2 Combinations of a mek inhibitor compound with an her3/egfr inhibitor compound and methods of use |
| 09/25/2014 | WO2014152232A2 Anti-plasma kallikrein antibodies |
| 09/25/2014 | WO2014152157A2 Methods and compositions for the generation and use of conformation-specific antibodies |
| 09/25/2014 | WO2014152121A1 Mono or multivalent botulinum neurotoxin based vaccine using the heavy chain from serotypes of clostridium botulinum |
| 09/25/2014 | WO2014152092A2 Methods and compositions for modulating regulatory t cell function |
| 09/25/2014 | WO2014152006A2 Anti-hepcidin antibodies and uses thereof |
| 09/25/2014 | WO2014151953A1 Compounds and methods for inducing chondrogenesis |
| 09/25/2014 | WO2014151917A1 Compositions and methods for treating angiogenesis-related disorders |
| 09/25/2014 | WO2014151866A1 Compositions and methods for diagnosis and treatment of hepatic cancers |
| 09/25/2014 | WO2014151855A1 Compositions and methods for live, attenuated alphavirus formulations |
| 09/25/2014 | WO2014151747A1 Methods and compositions with immune therapy for treatment of dementia |
| 09/25/2014 | WO2014151734A1 Fusion proteins and methods thereof |
| 09/25/2014 | WO2014151687A2 Compositions and methods to treat aids |
| 09/25/2014 | WO2014151680A1 Treatment and prevention of acute kidney injury using anti-alpha v beta 5 antibodies |
| 09/25/2014 | WO2014151648A1 Treatment of autoimmune disease using helminthic parasites |
| 09/25/2014 | WO2014151526A1 Biological therapeutics for infection-relating disorders or conditions |
| 09/25/2014 | WO2014151488A1 Improved stability and potency of hemagglutinin |
| 09/25/2014 | WO2014151403A1 Method and apparatus for boosting vaccine efficacy |
| 09/25/2014 | WO2014151401A1 CROSS-PROTECTION OF BOVINES AGAINST B. trehalosi INFECTION BY A MULTI-VALENT VACCINE |
| 09/25/2014 | WO2014151279A1 Vaccines having an antigen and interleukin-23 as an adjuvant |
| 09/25/2014 | WO2014151265A1 Methods and compositions for stimulating immune response |
| 09/25/2014 | WO2014150939A2 Compositions and methods for dengue virus chimeric constructs in vaccines |
| 09/25/2014 | WO2014150840A1 Methods of treating breast cancer |
| 09/25/2014 | WO2014150835A1 Influenza nucleic acid molecules and vaccines made therefrom |
| 09/25/2014 | WO2014150822A2 Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use |
| 09/25/2014 | WO2014150720A1 Compositions and methods relating to inhibiting cancer cell growth and/or proliferation |
| 09/25/2014 | WO2014150718A1 Intra-testicular injection of immunogens |
| 09/25/2014 | WO2014150655A1 Methods of cell culture |